![Insights from 2023 ASH Annual Meeting](http://media.vumedi.com/thumbs/channel_logo/2023/12/d8f4a042-951d-471d-8892-527b15ad5587.png.200x0_q85.png)
Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
TN-CLL/SLL: Combination Treatment With Sonrotoclax (BGB-11417), a 2nd-Gen BCL2i, and Zanubrutinib
By
Insights from 2023 ASH Annual Meeting
FEATURING
Mary Ann Anderson
By
Insights from 2023 ASH Annual Meeting
FEATURING
Mary Ann Anderson
176 views
December 14, 2023
Login to view comments.
Click here to Login
Leukemia